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Abstract
Background: In Germany, testing and treatment of sexually transmissible infections (STIs) services are not provided
by one medical discipline, but rather dispersed among many different providers. Common STIs like gonorrhoea or
Chlamydia infection are not routinely reported. Although men who have sex with men (MSM) are particularly
vulnerable to STIs, respective health care utilization among MSM is largely unknown.
Methods: A sexual behaviour survey among MSM was conducted in 2006. Questions on self-reported sexual
behaviour, STI-related health care consultation and barriers to access, coverage of vaccination against hepatitis,
screening for asymptomatic STIs, self-reported history of STIs, and partner notification were analysed. Analysis was
stratified by HIV-serostatus (3,511 HIV-negative/unknown versus 874 positive).
Results: General Practitioners, particularly gay doctors, were preferred for STI-related health care. Low threshold testing
in sex-associated venues was acceptable for most respondents. Shame and fear of homophobic reactions were the
main barriers for STI-testing. More than half of the respondents reported vaccination against hepatitis A/B. HIV-positive
MSM reported screening offers for STIs three to seven times more often than HIV-negative or untested MSM. Unlike
testing for syphilis or hepatitis C, screening for asymptomatic pharyngeal and rectal infections was rarely offered. STIs in
the previous twelve months were reported by 7.1% of HIV-negative/untested, and 34.7% of HIV-positive respondents.
Conclusions: Self-reported histories of STIs in MSM convenience samples differ significantly by HIV-serostatus.
Higher rates of STIs among HIV-positive MSM may partly be explained by more testing. Communication between
health care providers and their clients about sexuality, sexual practices, and sexual risks should be improved. A
comprehensive STI screening policy for MSM is needed.
Keywords: Sexual Behaviour [MeSH], Delivery of Health Care [MeSH], Health Surveys [MeSH], Sexually Transmitted
Diseases [MeSH], Men who have sex with men (MSM) [non-MeSH]
Background
In Germany, it is difficult to measure the burden of
sexually transmissible infections (STIs), particularly
among hidden or marginalised sub-populations like men
who have sex with men (MSM).
First, STI diagnosis and therapy services are not con-
centrated in Genito-Urinary Medicine (GUM) or STI
clinics (like e.g. in the UK), but dispersed among different
medical disciplines: general practitioners (GPs), derma-
tologists/venerologists, urologists, and private or hospi-
tal-attached HIV outpatient clinics with a large clientele
of MSM. Last but not least, German Public Health
Offices (PHOs) historically offer anonymous counselling
and testing for some STIs, including HIV.
Second, the German infectious diseases surveillance
system was altered in 2001, and since then mandates
reporting of only a few STIs: HIV, syphilis and acute
hepatitis B virus infection. An additional sentinel system* Correspondence: MarcusU@rki.de
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for STI surveillance was established in 2002; but results
are highly biased [1].
Since 2001, increasing numbers of newly diagnosed
syphilis and HIV infections among MSM have been
observed [2,3]. This prompted us to plan a national sur-
vey on knowledge, attitudes, and behaviour as to sexually
transmissible infections (KABaSTI) among MSM in Ger-
many, piloting the establishment of a system of second
generation HIV/STI surveillance in MSM. Due to reports
suggesting that MSM with diagnosed HIV infection are
particularly affected by other STIs [4] we decided to over-
sample HIV positive MSM by choosing health care facil-
ities and a bareback website as study recruitment sites in
addition to general chat and dating websites for MSM.
With this survey we aimed to monitor STI-related
knowledge, sexual behaviour, STI risk due to sexual net-
work characteristics, STI-related health care consultation
and barriers to access, coverage of vaccination against
hepatitis, screening for asymptomatic STIs, self-reported
recent and lifetime history of STIs, and partner
notification.
Methods
The survey was conducted in 2006, using an anonymous,
self-administered, 66-item questionnaire. Details have
been described elsewhere [5]. In summary, seven German
language chat and dating websites for MSM provided
links to an online questionnaire, including a website par-
ticularly for gay men who prefer anal sex without con-
doms (’bareback website’). In addition, participants were
enrolled offline in 76 private medical practices or out-
patient clinics who - based on syphilis notifications - deal
with a high proportion of MSM among their patients.
Participating medical facilities received print question-
naires for distribution to all recognizable male homosex-
ual or bisexual clients. Participants were asked to return
the questionnaire anonymously and in a prepaid envel-
ope. No incentives were provided for completing the
questionnaire.
For this report, we analysed questions on (1) sexual
behaviour and diagnosed STIs or HIV among sexual part-
ners, (2) STI-related health care consultation and barriers
to access (3), coverage of hepatitis A/B vaccination, (4)
diagnostic coverage of asymptomatic STIs (screening), (5)
history of various STIs during lifetime and in the previous
twelve months (referred to as ‘recent’ diagnoses), and (6)
partner notification (for an English translation of the ques-
tions see Additional file 1). Analysis of online respondents
was restricted to completed datasets. Analyses were strati-
fied by self-reported HIV status, and odds ratios were cal-
culated to compare respondents who were diagnosed
HIV-positive with those who were not. To evaluate the
impact of HIV serostatus on STI-screening, we conducted
logistic multivariate regression analysis using IBM® SPSS®
Statistics 18. Diagnosed STIs were additionally stratified
by recruitment site.
Results
Among the total of 4,385 respondents eligible for analy-
sis, 3,511 reported a negative last HIV test result or no
previous HIV test, and 874 reported a positive HIV test
result. HIV-negative and untested men were predomi-
nantly recruited on general MSM chat and dating web-
sites (n = 3,050), while large proportions of HIV-positive
respondents were recruited on a ‘bareback’ website (n =
240), and in medical facilities (n = 417). Other socio-
demographic data on the two subsamples are reported in
table 1.
No differences were found between drop outs (i.e.
respondents with incomplete data; n = 2,265) and the
HIV-negative/untested group of respondents with
respect to age, city-size, education, being recruited on a
‘bareback’ website, or frequency of anal intercourse with
non-steady partners; drop outs had slightly fewer sexual
partners (24.6% vs. 27.7% with more than 10 partners).
Within the HIV-negative/untested group, respondents
who were never tested for HIV (n = 1,144) were
younger, living in smaller cities, had lower educational
degrees, and reported fewer sexual partners, less unpro-
tected sex, and fewer STIs. Despite this heterogeneity
they were grouped together with the HIV-negative
respondents, as from the health care point of view,
MSM who had a negative HIV test in the past are not
regarded as different from MSM who did not, while
screening and recommendations regarding some diag-
nostic procedures differ for MSM who are HIV-positive.
(1) Sexual behaviour and diagnosed STIs or HIV among
sexual partners
The proportion of respondents with more than ten sexual
partners in the previous twelve months (table 1) was
higher among HIV-positive MSM as compared to HIV-
negative or untested MSM; the same holds true for fre-
quently engaging in anal sex (both receptive and insertive),
and for engaging in anal sex without a condom. More
than a quarter of the HIV-positive and 6.3% of the HIV-
negative/untested MSM reported five or more episodes of
unprotected anal intercourse (UAI) with a partner of
unknown (or discordant) HIV serostatus during the last
twelve months (’frequent risk-taking’). Most of these
reported risky sexual encounters occurred in settings
where sexual partners were anonymous.
As the risk of acquiring an STI is the result of both an
individual’s sexual behaviour and the prevalence of STIs
within his sexual networks, we asked for sexual partners
who were known to be HIV positive or to have been diag-
nosed with syphilis, gonorrhoea, or Chlamydia infection in
the previous 12 months. HIV-positive respondents
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reported not only a substantially higher proportion of sex-
ual partners with HIV, but also a higher proportion of sex-
ual partners with recent STIs than HIV-negative/untested
respondents.
(2) STI-related health care consultation and barriers to
access
If suspecting an STI, about half of the respondents in
both serostatus groups said they would visit a General
Practitioner (table 2). Compared to HIV-positive MSM,
the proportion of HIV-negative/untested MSM who
chose the possibility of anonymous STI consultation at a
Public Health Office (PHO) was twice as high. Almost
80% of HIV-negative/untested respondents would con-
sider low threshold STI-testing in bars, discos, or saunas,
if offered, but only 60.3% of HIV-positive respondents.
The main barrier for not seeking medical treatment was
‘shame’ (44.0%). Other frequently mentioned barriers were
men’s inability to talk to their physician about having sex
with men (37.0%), or discomfort with talking about sex in
general (23.0%). ‘Shame’ and the perceived inability to talk
about sex with men were strongly correlated with city size
- and most pronounced among respondents residing in
rural areas or small towns. Taken together, communica-
tion issues as barriers for health care consultation were
reported by 45.3% of HIV-negative/untested and 20.6% of
HIV-positive respondents (table 2). Among online
respondents, previous experience with STIs (and thus with
medical personnel) lowered both fear and shame. How-
ever, three in four respondents expressed a preference for
consulting an STI doctor who is gay - particularly MSM
recruited in medical facilities, among whom perceived
communication barriers were lowest (17.2%).
Financial constraints were least frequently reported as
a barrier for seeing a physician (15.2%). Reporting finan-
cial barriers increased with declining incomes (retired:
20%; workers: 22%; unemployed: 33%).
(3) Coverage of Hepatitis A/B vaccination
A majority of respondents in both serostatus groups
reported being vaccinated against hepatitis A and B (table
2). Hepatitis vaccination status was negatively correlated
with age: In Germany, vaccination against hepatitis B has
been recommended for children and adolescents since
1995, and costs are covered by statutory health insurances.
Among respondents 44 years of age or older 49% reported
being vaccinated against hepatitis B (hepatitis A: 48%),
while among those younger than 20 years of age the
respective proportion was 79% (hepatitis A: 73%).
(4) Diagnostic coverage of asymptomatic STIs (screening)
Of MSM reporting no positive HIV diagnosis, 67.4% had
ever tested for HIV and 25.3% were tested recently, in the
previous 12 months (table 2). Among non-HIV-positive
Table 1 Demographic characteristics and sexual behaviour in two sub-samples of MSM in Germany: n (%)
Last HIV test negative
or not tested for HIV
n = 3,511
HIV-positive
n = 874
OR (95%-CI)/p
Recruitment and Demographics
Recruitment <0.001 (c2)
Chat- and Dating Websites 3,050 (86.9) 217 (24.8)
’Bareback’ Website 207 (5.9) 240 (27.5)
Medical Facilities 254 (7.2) 417 (47.7)
Median age (range) 32 (16; 76) 40 (20; 70) >0.001 (t)
City size (population >500,000) 1,218 (34.7) 467 (53.4) 2.16 (1.86-2.51)
Education (ISCED 4 or higher) 1,836 (52.3) 414 (47.4) 0.82 (0.71-0.95)
Sexual behaviour in the previous 12 months
More than ten sexual partners 974 (27.7) 466 (53.3) 2.98 (2.56-3.64)
Sex with non-steady partners was...
frequently anally insertive 820 (23.4) 337 (38.6) 2.06 (1.76-2.41)
frequently anally receptive 792 (22.6) 382 (43.7) 2.67 (2.82-3.11)
Frequent HIV risk-taking*
with male partners in general 222 (6.3) 233 (26.7) 5.39 (4.40-6.59)
with anonymous partners 135 (3.8) 208 (23.8) 7.81 (6.19-9.85)
Sexual Networks: Reporting sexual partners with...
HIV 209 (6.0) 425 (48.6) 14.96 (12.33-18.13)
recent STIs** 178 (5.1) 192 (22.0) 5.27 (4.23-6.57)
*Frequent risk-taking: Five or more episodes of unprotected anal intercourse with a non-steady sexual partner of unknown or discordant HIV serostatus in the
previous twelve months; **Current sexual partners with recent STIs: diagnosed with syphilis, gonorrhoea, or Chlamydia infection in the previous twelve months.
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Table 2 STI-related health care, coverage of hepatitis A/B vaccination, screening for STIs, diagnosed STIs, and partner
notification in two sub-samples of MSM in Germany: n (%); results for lifetime and the previous 12 months
Last HIV test negative
or not tested for HIV
n = 3,511
HIV-positive
n = 874
OR (95%-CI)/p
STI-related health care
Preferred STI care provider <0.001 (c2)
General Practitioner 1,637 (46.6) 448 (51.3)
Dermatologist 590 (16.8) 243 (27.8)
Urologist 808 (23.0) 118 (13.5)
Public Health office 475 (13.5) 55 (6.3)
Low threshold testing* 2,806 (79.9) 527 (60.3) 0.38 (0.33-0.45)
Would prefer a gay physician 2,529 (72.0) 614 (70.3) 0.92 (0.78-1.08)
Communication barriers** 1,589 (45.3) 180(20.6) 0.31 (0.26-0.37)
Last 12 m. Lifetime Last 12 m. Lifetime
Medical consultation for STIs 757 (21.6) 433 (49.5) 3.57 (3.06-4.17)
1,327 (37.8) 597 (68.3) 3.55 (3.03-4.15)
No medical consultation*** 190 (5.4) 28 (3.2) 0.58 (0.39-0.87)
Hepatitis A vaccination 1,932 (55.0) 566 (64.8) 1.50 (1.23-1.75)
Hepatitis B vaccination 2,045 (58.8) 577 (66.0) 1.39 (1.19-1.63)
Self-reported testing/screening§
Last 12 m. Lifetime Last 12 m. Lifetime
HIV 888 (25.3)§§ 2,367 (67.4) 183 (20.9)§§ n.a. n.a.
HCV 787 (22.4) 437 (50.0) 3.46 (2.97-4.04)
1,223 (34.8) 577 (66.0) 3.64 (3.11-4.25)
Chlamydia 264 (7.5) 220 (25.2) 4.14 (3.40-5.04)
415 (11.8) 300 (34.4) 3.90 (3.28-4.64)
Syphilis 556 (15.8) 472 (54.0) 6.24 (5.31-7.33)
799 (22.8) 584 (66.8) 6.84 (5.82-8.03)
Gonorrhoea (rectal) 240 (6.8) 177 (20.3) 3.46 (2.90-4.27)
352 (10.0) 248 (28.4) 3.56 (2.96-4.27)
Gonorrhoea (pharyngeal) 232 (6.6) 159 (18.2) 3.14 (2.53-3.91)
330 (9.4) 223 (25.5) 3.30 (2.73-3.99)
Any of the above (not HIV) 992 (28.3) 572 (65.4) 4.81 (4.11-5.63)
1,522 (43.3) 713 (81.6) 5.79 (4.82-6.95)
Self-reported diagnoses
Last 12 m. Lifetime Last 12 m. Lifetime
HCV 13 (0.4) 38 (4.3) 12.23 (6.49-23.06)
29 (0.8) 77 (8.8) 11.60 (7.52-17.90)
Chlamydia 66 (1.9) 104 (11.9) 7.05 (5.13-9.69)
199 (5.7) 233 (26.7) 6.05 (4.92-7.44)
Syphilis 84 (2.4) 138 (15.8) 7.65 (5.77-10.15)
232 (6.6) 366 (41.9) 10.18 (8.43-12.30)
Gonorrhoea (urethral) 105 (3.0) 117 (13.4) 5.01 (3.81-6.60)
459 (13.1) 357 (40.8) 4.59 (3.89-5.43)
Gonorrhoea (rectal) 28 (0.8) 39 (4.5) 5.81 (3.56-9.50)
66 (1.9( 127 (14.5) 8.87 (6.52-12.07)
Gonorrhoea (pharyngeal) 12 (0.3) 17 (1.9) 5.78 (2.75-12.15)
37 (1.1) 39 (4.5) 4.39 (2.78-6.92)
Any of the above (not HIV) 249 (7.1) 303 (34.7) 6.95 (5.75-8.40)
745 (21.2) 616 (70.5) 8.87 (7.51-10.47)
Of those: Informed partner(s) 125 (50.2) 152 (50.2) 1.0 (0.71-1.39)
*Low threshold testing: No general objection to testing campaigns in bars, discos, or saunas; **Communication barriers: Respondents who said the most important
reason for not consulting a health care provider although suspecting to have acquired an STI was ‘shame’, or a feeling that talking about sex in general, or about
sex with men, was not possible with their health care provider(s); *** No medical consultation: Proportion of respondents who said they did not consult a health
care provider despite having symptoms or knowing that a sexual partner had an STI; § Self-reported testing/screening: Latest HIV antibody test; tested for STIs in
the absence of specific symptoms? §§ Latest HIV test in 2005 or 2006 (i.e. within the previous 18 months); assuming that HIV-testing is equally spread over the
year, this value was adjusted to 12 months
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men, one in four respondents from general MSM websites
underwent HIV-testing in the previous twelve months,
while among men recruited on a ‘bareback website’ or in
medical facilities, it was one in two. Lifetime and recent
history of STI-screening differed substantially between
HIV-positive and HIV-negative/untested MSM. Moreover,
being screened for STIs was more likely to be offered if
possible to be done by serological testing. Screening for
STIs requiring swab-testing or microbiological culturing
for diagnosis, such as rectal or pharyngeal infections with
Chlamydia or Gonococci, was only half as likely as for
STIs requiring serological testing (table 2).
HIV serostatus, not sexual behaviour, was the key
determinant of reported screening. Among HIV-positive
respondents reporting sexual contacts with only one
man in the last twelve months, 65.6% were screened in
the past year for STIs other than HIV. In contrast, of
respondents without HIV diagnosis, but with more than
fifty sexual partners in the last twelve months, the pro-
portion screened for other STIs was only 28.2%. Even if
the latter group was restricted to men who reported
recent testing for HIV, and thus a history of HIV-related
risk-taking and contact with the health care system, less
than half of them were simultaneously tested for syphilis
(46.0%), hepatitis C (45.1%), Chlamydia infection
(25.3%), pharyngeal gonorrhoea (18.7%), or rectal gonor-
rhoea (17.6%).
In multivariate regression analysis, HIV-serostatus was
the strongest predictor for STI-screening in the previous
12 months (OR = 3.8; 95% confidence interval: 3.2-4.5)
followed by the number of sexual partners (reference: 0-
1 sexual partners in the last 12 months): 2-10 partners
(1.5; 1.3-1.8), 11-20 partners (2.1; 1.6-2.6), and more
than 20 partners (2.6; 2.1-3.2). Other independently
associated factors included being 25 years of age or
older (1.3; 1.1-1.6), living in a city with more than
500,000 inhabitants (1.2; 1.1-1.4), or frequently engaging
in receptive anal intercourse with non-steady partners
(1.2; 1.0-1.4). On the other hand, frequently engaging in
insertive anal intercourse with non-steady partners,
reporting unprotected anal intercourse with non-steady
or anonymous partners of unknown or discordant HIV-
status, a general positive attitude towards condom use
for STI prevention, or education, were not associated
with STI-screening.
(5) Self-reported STIs: lifetime and previous 12 months
Recently diagnosed HIV infections were most frequent
among respondents from the ‘bareback website’ (13.7%);
among MSM from other websites, the respective value
was a magnitude lower (1.7%).
The most frequently reported STI was urethral gonor-
rhoea, followed by syphilis. Rectal and pharyngeal infec-
tions with Gonococci were reported as 3-4 times less
frequent. All recently diagnosed STIs - particularly
hepatitis C and syphilis - were substantially more fre-
quent among HIV-positive respondents, as were lifetime
diagnoses of STIs (table 2). Higher proportions of
respondents recruited on a ‘bareback’ website reported
recently diagnosed STIs, even if compared with respon-
dents recruited in medical facilities who had a higher
prevalence of diagnosed HIV infection (table 3).
(6) Partner notification (PN)
Of those who reported a recent diagnosis of one of the
abovementioned STIs (not HIV), 50.2% said they had
informed their sexual partner(s). The most important
reason for non-notification was not ‘shame’ (15.6%), or
carelessness (13.2%), but the anonymity of many sexual
partners (82.0%). Informing others about diagnosed STIs
was highly associated with reporting that they had been
informed by sexual partners about STI diagnoses (OR =
3.8; 95%-CI: 3.0-4.9). No differences were found between
the Eastern and Western part of Germany. Respondents
recruited in medical facilities were much more likely to
report PN than respondents recruited online (table 3).
Discussion
We found high rates of diagnosed STIs - during lifetime
and the previous twelve months - among MSM
recruited on chat and dating websites and in medical
facilities, although testing rates for STIs in our sample
tend to be lower than in published samples from other
countries [6,7].
However, since the sample is a convenience sample,
these rates cannot be expected to be representative of
the German gay or MSM population. A self-selection
bias favouring men with increased risk for HIV and
STIs has to be expected.
Based on estimates of the total size of the identifiable
MSM population in Germany [8], data from German
STI-sentinels, and biological surveillance data, expected
proportions of recent syphilis diagnoses among MSM
with/without HIV infection can be calculated. If these
proportions are compared to the respective proportions
of reported recent syphilis among MSM with/without
HIV infection, the level of self-selection bias can be
assessed, using a calculation to measure the self-selection
factor (figure 1).
When entering German data into this formula, self-
selection bias results in factor 3-5 for HIV-positive respon-
dents and in factor 10 for HIV-negative respondents.
However, even taking this considerable self-selection bias
into account, the burden of STIs in the MSM population
is still significantly higher than in the heterosexual
population.
In addition, other research has shown that among
MSM, non-genital manifestations of gonorrhoea and
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Chlamydia infection are at least as frequent as genital
manifestations [9], and that the majority of bacterial
STIs are present without noticeable symptoms [9-11].
Since systematic screening for pharyngeal and rectal
infections was quite rare in our sample, rectal/pharyn-
geal gonorrhoea and rectal/urethral Chlamydia infec-
tions are almost certainly underdiagnosed.
The comparatively minor role of reported Chlamydia
infections can further be attributed to considerable
knowledge gaps regarding Chlamydia among German
MSM. Moreover, a widespread clinical practice of syn-
dromic treatment for suspected Chlamydia infections
might preclude a sound diagnostic approach.
The differences between STI diagnosis rates among
HIV-positive and HIV-negative/untested respondents
are substantial. However, since many of the STIs we
looked at in this analysis may be present without caus-
ing characteristic symptoms, the large differences
between reported STI screening rates likely will have an
impact on the frequencies of diagnoses.
The finding that HIV-infected MSM were more likely
to be evaluated for STIs than their non-infected coun-
terparts may suggest one of three things: 1) given their
risk profile, they may be more likely to present with
symptomatic STIs; 2) they may feel more comfortable
with their HIV care provider than others feel with their
providers and thus more willing to share concerns
about risk behaviours and STIs; or 3) their HIV care
providers may be more pro-active in assessing ongoing
risk behaviours and suggesting STI testing among their
clientele.
Higher STI screening rates among HIV-positive
patients in Germany are likely due to more intense con-
tact with health care providers and fewer reimbursement
problems if screening tests are prescribed in the context
of health care provision for HIV infection. However, even
for usually symptomatic STIs, such as urethral gonor-
rhoea, for which numbers of diagnoses are less biased by
screening activities, a several-fold higher disease burden
is reported by HIV-positive MSM compared to HIV-
negative/untested men. Reasons for these differences
may be related to higher partner numbers and less con-
sistent condom use among HIV positive men. The role of
HIV-serosorting has been analysed and discussed else-
where [12].
Other biases in our results are related to sample char-
acteristics: MSM recruited in medical facilities by defini-
tion already have access to STI-related care (60% among
those medical facilities were specialised in HIV treat-
ment). Results from this sub-sample therefore are likely
to overestimate the burden of diagnosed STIs, particu-
larly among HIV-negative MSM, and to underestimate
specific barriers towards STI-related health care.
We are not able to define response rates for partici-
pants recruited on different websites, but we reach very
different populations on general MSM and ‘bareback’
websites. Due to the higher numbers of sexual partners
and the higher frequency of unprotected anal intercourse
among MSM recruited on a ‘bareback website’, this sub-
sample may represent an important part of ‘STI core
groups’ among MSM. Such core groups are necessary to
Table 3 Diagnosed STIs, stratified by recruitment method: n (%); results for lifetime and the previous 12 months
Chat- & Dating Sites
n = 3,267
’Bareback’ website
n = 447
Medical Facilities
n = 671
Last 12 m. Lifetime Last 12 m. Lifetime Last 12 m. Lifetime
HIV 55 (1.7)§ 217 (6.6) 61 (13,7)§ 240 (53.7) 68 (10,1)§ 417 (62.1)
HCV 16 (0.5) 33 (1.0) 16 (3.6) 27 (6.0) 19 (2.8) 46 (6.9)
Chlamydia 69 (2.1) 191 (5.8) 46 (10.3) 106 (23.7) 55 (8.2) 135 (20.1)
Syphilis 81 (2.5) 238 (7.3) 77 (17.2) 169 (37.8) 64 (9.5) 191 (28.5)
Gonorrhoea (urethral) 101 (3.1) 425 (13.0) 74 (16.6) 180 (40.3) 47 (7.0) 211 (31.4)
Gonorrhoea (rectal) 26 (0.8) 76 (2.3) 19 (4.3) 49 (11.0) 22 (3.3) 68 (10.1)
Gonorrhoea (pharyngeal) 14 (0.4) 36 (1.1) 5 (1.1) 20 (4.5) 10 (1.5) 20 (3.0
Any of the above (not HIV) 233 (7.1) 688 (21.1) 167 (37.4) 293 (65.5) 152 (22.7) 380 (56.6)
Of those: Informed partner(s) 98 (42.1) 68 (40.7) 111 (73.0)
§ Latest HIV test in 2005 or 2006 (i.e. within the previous 18 months); assuming that HIV-testing is equally spread over the year, this value was adjusted to 12
months
stu
pop
pop
stu
N
N
S
SSSB
Figure 1 Assessment of self-selection bias. SSB self-selection bias;
Sstu, Spop: self-reported Syphilis diagnoses in the last 12 months in
the study (stu)/Syphilis cases attributed to MSM in the primary
surveillance data (pop); Nstu, Npop: Number of MSM in the study (stu)/
in the German population (pop), the latter based on extrapolations
from sexual behaviour surveys of the general population.
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maintain continuous circulation of bacterial STIs, which
usually have a limited period of infectiousness and can
easily be cured by antibiotic treatment (table 3).
Experiences with partner notification (PN) in Germany
are mixed: In the Eastern part, until re-unification in
1990, partner tracing for patients with STIs was manda-
tory; the Western policy relied on physicians encouraging
patients to inform their sexual partner(s). In this survey,
PN was relatively frequent, with no differences between
East and West. For MSM, anonymity of sexual partners
seems to be the main obstacle against PN. Given today’s
impact of Internet-based search for sexual partners, the
use of ‘new’ technologies like SMS or chat room mes-
sages, as being reported from e.g. San Francisco or Syd-
ney, should be implemented and evaluated for PN among
MSM in Germany [13-15].
Although it is unclear to what extent respondents can
distinguish between hepatitis A and hepatitis B, it is reas-
suring that the broad implementation of hepatitis B vac-
cination in 1995 [16] has resulted in high proportions of
vaccinated MSM in younger age-groups. This is particu-
larly reassuring, as the efficacy of hepatitis B vaccination
after HIV infection is reduced [17].
Low threshold STI-testing at sex-associated gay venues
is an option for improving the uptake of STI-testing;
however, MSM at high risk for STIs expressed some
reservations, particularly HIV-positive men. Concerns
might be related to fears of loss of privacy, restrictive
measures, or further stigmatization [18]. The acceptance
of such testing approaches needs to be evaluated sepa-
rately for different settings.
Approximately 90% of the German population is cov-
ered by statutory health insurance [19]. Except for a quar-
terly consultation fee (since 2004), these patients do not
have to deal with costs of medical procedures, and are not
used to paying for diagnostic tests. German statutory
health insurance reimbursement rules for laboratory STI-
testing include incentives only for notifiable STIs. This
might explain why STI-screening as shown in our results
is mainly restricted to syphilis, HIV, and HCV - although
sexually acquired hepatitis C is highly uncommon among
HIV-negative MSM [20]. With growing awareness about
increasing HCV transmission among HIV-positive MSM,
some health care providers seem to include HCV screen-
ing into routine health checks.
Although recommended (e.g. by the German STD
society), screening for asymptomatic bacterial STIs,
including pharyngeal and rectal swabs for Gonococci, or
nucleic acid testing of urine or rectal swabs for Chlamydia,
is thus rarely offered. It has been described repeatedly that
GPs or infectious disease specialists tend to neglect sexual
health care needs of at-risk patients or sexual minorities
[6,21], beyond financial aspects. The discrepancy between
over-testing HIV-positive gay men - even if presently at
low risk for STIs - and not offering syphilis serology to
MSM with many sexual partners is striking.
Conclusions
The implementation of a comprehensive STI-screening
program for sexually active MSM is urgently needed,
but hampered by communication barriers. Talking
about sexuality in general, about homosexual contacts in
particular, or about marginalised, delicate, or MSM-spe-
cific sexual practices (frequent anal/oral intercourse
with non-steady partners, ‘rimming’, ‘fisting’, etc.) is still
an obstacle to adequate testing-strategies - particularly
in smaller towns, or in health care facilities where MSM
fear to be confronted with homophobic reactions. Train-
ing GPs in taking sexual histories, assessing sexual risks,
and providing non-judgmental sexual health care would
be a key step to improving sexual health care for MSM
and other patients at risk for STIs [22].
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